Showing results (701-710 of 4,070) with videos related to
Sort By:
Pageof 407
American Journal of Ophthalmology|April 6, 2005
Retained antibiotic ophthalmic ointment on an intraocular lens 34 months after sutureless cataract surgeryKo-Hua Chen, Shan-Yang Lin, Mei-Jane Li, et al.Graefe'S Archive for Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Fur Klinische Und Experimentelle Ophthalmologie|September 1, 2005
Corneal calcification: chemical composition of calcified depositKo-Hua Chen, Wen-Ting Cheng, Mei-Jane Li, et al.International Journal of Systematic and Evolutionary Microbiology|October 19, 2022
Tabrizicola rongguiensis sp. nov., isolated from the sediment of a river in Ronggui, Foshan city, ChinaJiarou Xu, Tongchu Deng, Youda Huang, et al.Investigative Radiology|September 11, 2019
A Practical Guide to Artificial Intelligence-Based Image Analysis in RadiologyThomas Weikert, Joshy Cyriac, Shan Yang, et al.Drug Discovery Today|June 23, 2019
LMWH and its derivatives represent new rational for cancer therapy: construction strategies and combination therapyShi Du, Yao Yu, Cheng Xu, et al.Annals of Clinical and Laboratory Science|November 13, 2024
Hemolytic Transfusion Reactions Due to Lea and Leb AntibodiesHai-Yan Li, Li-Jun Li, Deng-Shan Yang, et al.Journal of Hazardous Materials|May 4, 2024
Reduction of selenite to selenium nanoparticles by highly selenite-tolerant bacteria isolated from seleniferous soilMeng Ge, Shaofeng Zhou, Daobo Li, et al.Frontiers in Medicine|January 26, 2024
Corrigendum: Possible risk factors of opaque bubble layer and its effect on high-order aberrations after small incision Lenticule extractionShan Yang, Heng Wang, Zhengyu Chen, et al.Inflammation Research : Official Journal of the European Histamine Research Society ... [Et Al.]|September 2, 2023
Pirfenidone ameliorates liver steatosis by targeting the STAT3-SCD1 axisShan Yang, Renzi Zhang, Wenzhen Deng, et al.International Journal of Nanomedicine|June 14, 2023
Combat Against Gynecological Cancers with Blood Vessels as Entry Point: Anti-Angiogenic Drugs, Clinical Trials and Pre-Clinical Nano-Delivery PlatformsShan Yang, Weidong Fei, Yunchun Zhao, et al.Pageof 407